Patient characteristics | Sensitivity | Specificity | PPV | NPV | Acc | LR+ | LR- |
---|---|---|---|---|---|---|---|
All patients (N = 317) | |||||||
Positive cTnI | 71 (55-84) | 97 (94 to 98) | 78 (62 to 89) | 95 (92 to 97) | 93 (90 to 96) | 21.5 (20.1 to 22.9) | 0.32 (0.23 to 0.36) |
Positive HScTnT | 93 (89 to 100)* | 82 (77 to 87)* | 47 (36 to 58)* | 99 (96 to 100) | 84 (79 to 88)* | 5.3 (4.8 to 5.8) | 0.08 (0.04 to 0.12) |
Low to moderate PTP group (n = 258) | |||||||
Positive cTnI | 77 (54 to 92) | 97 (94 to 99) | 71 (49 to 87) | 98 (95 to 99) | 95 (92 to 97) | 26.1 (24.0 to 28.1) | 0.23 (0.17 to 0.30) |
Positive HScTnT | 91 (69 to 98) | 85 (79 to 89)* | 36 (24 to 49)** | 99 (96 to 100) | 85 (80 to 89)* | 6.0 (5.3 to 6.6) | 0.11 (0.06 to 0.15) |
High PTP group (n = 59) | |||||||
Positive cTnI | 65 (43 to 83) | 94 (79 to 99) | 88 (62 to 98) | 81 (65 to 91)* | 83 (71 to 91)** | 11.7 (10.1 to 13.4) | 0.37 (0.18 to 0.55) |
Positive HScTnT | 96 (76 to 100)*** | 67 (49 to 81)*** | 65 (47 to 81) | 96 (78 to 100) | 78 (65 to 87) | 2.9 (2.3 to 3.4) | 0.07 (0 to 0.17) |